Article Details


Sayali Churia and Tabassum Khana *

a Department of Pharmaceutical Chemistry & QA, SVKM’s Dr. Bhanuben Nanavati College of Pharmacy, Mithibai College Campus, V.L. Mehta Road, Vile Parle (West), Mumbai – 400 056, Maharashtra, India

* For Correspondence: E-mail:


The family Lauraceae includes various genus in which Litsea has around 200-400 varieties which are widely scattered in the tropical and semi-tropical zones. In China, Litsea species are used traditionally in many disease conditions such as bone pain, diarrhoea, edema, dyspepsia, gastroenteritis and colds. Litsea glutinosa has been traditionally used in the treatment of tumors by the local people of Chittagong Hill Tracts, Bangladesh. Also, 15 other Litsea species are reported to have cytotoxic activity against various cancer cell lines, making this genus a promising potential source of anticancer compounds. This review provides comprehensive information about the cytotoxicity potential of various species in the genus Litsea along with secondary metabolites responsible, and its potential utility in lung, breast, hepatocellular, ovarian, prostate, colon and cervical cancer therapeutics as a botanical product. The published cytotoxicity data of these plants are mainly based on in vitro studies with very few molecular levels and mechanistic studies conducted. The optimistic results of these 16 species open unexplored vistas of natural product chemistry and the anticancer potential of this genus.

Year 2024 | Volume No. 61 | Issue No.2 | Page No. 7-22
Recent Issue
Current Issue
May 2024
Quick Contact